NNOX / Nano-X Imaging Ltd. (NNOX) Q3 2022 Earnings Call Transcript

Nano-X Imaging and its founder Ran Poliakine agreed to pay nearly $1.1 million to settle U.S. Securities and Exchange Commission charges accusing the more_horizontal

Nano-X is working to multiply the value of its top line in 2024. Its stock price will likely follow its sales upward at least part of the way. more_horizontal

The Food and Drug Administration recently granted marketing clearance for the company's X-ray system. Nano-X believes it can make medical imaging more more_horizontal

Nano-X now has approval from regulators in the U.S. to market its unique X-ray device. It'll be placing its systems mostly in places where there are f more_horizontal

Israeli medical tech firm Nano-X Imaging is the top-rated healthcare equipment stock as per Seeking Alpha's Quant Rating. We explore what's behind the more_horizontal

Nano-X Imaging now has regulatory approval to sell its device. As a result, it's signing agreements with customers around the world. more_horizontal

Nanox's medical device has been cleared by the FDA -- a key hurdle. The business is making headway in Africa, further fueling optimism. more_horizontal

Nano-X Imaging Ltd. (NNOX) reached a significant support level, and could be a good pick for investors from a technical perspective. more_horizontal